This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Miltenyi Biotec B.v. Co., Kg. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Ghaith Bakdash: Innovator in Cancer Treatment
Introduction
Ghaith Bakdash is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and inventions. With a total of 2 patents, Bakdash is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Ghaith Bakdash's latest patents focus on a cell population for use in treating cancer. The invention pertains to a cell population comprising CD1c (BDCA-1)/CD19 dendritic cells, which are specifically depleted for CD1c (BDCA-1)/CD19/CD14 cells. This innovative approach aims to enhance the effectiveness of cancer treatments and provide new hope for patients.
Career Highlights
Bakdash is currently associated with Miltenyi Biotec B.V. Co., Kg, where he continues to work on groundbreaking research in the field of oncology. His expertise and dedication have positioned him as a key figure in the development of advanced cancer therapies.
Collaborations
Throughout his career, Ghaith Bakdash has collaborated with esteemed colleagues, including Jolanda De Vries and Carl Gustav Figdor. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Ghaith Bakdash is a prominent inventor whose work in cancer treatment is paving the way for new therapeutic options. His contributions to the field are invaluable, and his ongoing research promises to make a significant impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile